A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1994
11/30/1994	EP0625909A1 Autoantibody assay and usage in the control of human disease
11/30/1994	EP0625908A1 Antidote for hirudin and synthetic thrombin inhibitors
11/30/1994	EP0625900A1 Compositions and processes for the sustained release of drugs.
11/30/1994	EP0574545B1 Phenyl amidines derivatives useful as platelet aggregation inhibitors
11/30/1994	CN1095724A Novel peptides the preparation and use thereof
11/29/1994	US5369094 Polypeptide bombesin antagonists
11/29/1994	US5369093 Lipopeptide derivatives
11/29/1994	US5369020 Method for suppressing coloring of human serum albumin
11/29/1994	US5369015 Method for producing an angiotensin converting enzyme inhibitor-containing composition
11/29/1994	US5368868 Nonionic surfactants of ethylene propylene oxide copolymers
11/29/1994	US5368858 Methods and compositions for the treatment and repair of defects or lesions in cartilage
11/29/1994	US5368854 Use of IL-10 to treat inflammatory bowel disease
11/29/1994	US5368853 Leukoregulin anti-viral therapy
11/29/1994	US5368051 Method of regenerating articular cartilage
11/29/1994	CA2124252A1 Method of reducing or preventing bone marrow hypoplasia
11/29/1994	CA1333264C Radiolabeled anti-platelet monoclonal antibody for imaging in-vivo thrombi
11/29/1994	CA1333258C Transmucosal formulations
11/28/1994	CA2124277A1 Methods for administering biological agents and microparticle compositions useful in these and other methods
11/27/1994	CA2124054A1 Octacyclodepsipeptides having an endoparasiticidal action
11/24/1994	WO1994027151A1 Utilization of molecules recognized by auto-antibodies of human serums for the diagnosis or treatment of aids
11/24/1994	WO1994027133A1 Method for selective opening of abnormal brain tissue capillaries
11/24/1994	WO1994026930A1 Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities
11/24/1994	WO1994026915A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/24/1994	WO1994026910A1 Immunotoxins comprising gelonin and an antibody
11/24/1994	WO1994026908A1 Cho cell sialidase by recombinant dna technology
11/24/1994	WO1994026897A2 Dna encoding two fish neuropeptides
11/24/1994	WO1994026896A1 Increased expression of alpha-1-antitrypsin in expression vectors through the inclusion of intron ii
11/24/1994	WO1994026893A1 Bmp-10 compositions
11/24/1994	WO1994026892A1 Bmp-11 compositions
11/24/1994	WO1994026891A2 Purified mammalian flt3 ligands and agonists and antagonists thereof
11/24/1994	WO1994026890A1 Hiv-1 tar rna binding protein
11/24/1994	WO1994026888A1 Inhibition of proliferation of vascular smooth muscle cell
11/24/1994	WO1994026887A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same
11/24/1994	WO1994026877A1 Ribozyme gene therapy for hiv infection and aids
11/24/1994	WO1994026786A1 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
11/24/1994	WO1994026785A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
11/24/1994	WO1994026784A1 Composition of antibodies against hepatitis b surface antigen
11/24/1994	WO1994026780A1 Synthetic aglucodalbaheptide antibiotics
11/24/1994	WO1994026779A1 PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS
11/24/1994	WO1994026778A1 Conjugation-stabilized polypeptide compositions
11/24/1994	WO1994026777A1 Thrombin inhibitors
11/24/1994	WO1994026776A1 Therapeutic compounds
11/24/1994	WO1994026774A1 Novel treatments for allergic diseases
11/24/1994	WO1994026773A1 Regulation of antigen presentation
11/24/1994	WO1994026760A1 SIALYL Lex ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
11/24/1994	WO1994026754A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
11/24/1994	WO1994026723A2 ras FARNESYL TRANSFERASE INHIBITORS
11/24/1994	WO1994026719A1 Mercapto-amide derivatives useful as neutral endopeptidase and ace inhibitors
11/24/1994	WO1994026718A1 3-aminoazepine compound and pharmaceutical use thereof
11/24/1994	WO1994026322A1 Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant
11/24/1994	WO1994026312A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE
11/24/1994	WO1994026308A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins
11/24/1994	WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	WO1994026306A1 Conserved motif of hepatitis c virus e2/ns1 region
11/24/1994	WO1994026302A1 Stable liquid compositions of gamma interferon
11/24/1994	WO1994026301A1 New peptide antagonists at glutamate and nmda receptors
11/24/1994	WO1994026300A1 Insulin-like growth factor ii as antitumour agent
11/24/1994	WO1994026298A1 Methods for treating muscle diseases and disorders
11/24/1994	WO1994026297A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
11/24/1994	WO1994026296A1 Novel opioid peptide inhibitors
11/24/1994	WO1994026293A1 Immunologic enhancement with intermittent interleukin-2 therapy
11/24/1994	WO1994026292A1 Amylin antagonists and agonists
11/24/1994	WO1994026291A1 Therapeutic inhibitor of vascular smooth muscle cells
11/24/1994	WO1994026290A1 Cytokine designated 4-1bb ligand and human receptor that binds thereto
11/24/1994	WO1994026289A1 Allogeneic and xenogeneic transplantation
11/24/1994	WO1994026287A1 Purification of plasma proteins
11/24/1994	WO1994026286A1 Oxygen-reduced aqueous solution of factor viii
11/24/1994	WO1994026284A1 Use of modified tall-104 cells to treat cancer and viral diseases
11/24/1994	WO1994026272A1 3-[n-(2-mercapto-propionyl-amino-acetyl)]-tetrahydro-thiazolyl-4-carboxylic acid as antiinflammatory and immunostimulating agent
11/24/1994	WO1994026265A1 16-hydroxytriptolide composition and method for immunotherapy
11/24/1994	WO1994026208A1 Methods and formulations for use in treating oophorectomized women
11/24/1994	WO1994026207A1 Methods and formulations for use in treating benign gynecological disorders
11/24/1994	WO1994026133A1 Antioxidant food, antioxidant preparation and antioxidization method
11/24/1994	WO1994026107A1 Psychosis protecting nucleic acid, peptides, compositions and method of use
11/24/1994	WO1994026106A1 Novel tracheal antimicrobial peptides
11/24/1994	WO1994023035A3 Recombinant timothy grass pollen allergen phl p ii
11/24/1994	WO1994023034A3 Variant insulin-like growth factor I receptor subunits and methods for use thereof
11/24/1994	WO1994020512A3 Analogs for specific oligosaccharide-protein interactions and uses therefor
11/24/1994	WO1994019466A3 A novel family of anti-carcinoembryonic antigen chimeric antibodies
11/24/1994	WO1994016073A3 Methods and reagents for inhibiting furin endoprotease
11/24/1994	WO1994015961A3 Synthetic amphipathic peptides with antimicrobial activity
11/24/1994	CA2555020A1 Inhibition of migration of inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	CA2165051A1 Dna encoding two fish neuropeptides
11/24/1994	CA2163234A1 Inhibition of proliferation of vascular smooth muscle cell
11/24/1994	CA2163219A1 Immunologic enhancement with intermittent interleukin-2 therapy
11/24/1994	CA2163129A1 Ribozyme gene therapy for hiv infection and aids
11/24/1994	CA2163105A1 Purified mammalian flt3 ligands and agonists and antagonists thereof
11/24/1994	CA2163020A1 Novel opioid peptide inhibitors
11/24/1994	CA2162868A1 Methods and compositions for detecting and treating mycobacterial infections using an inha gene
11/24/1994	CA2162715A1 3-aminoazepine compound and pharmaceutical use thereof
11/24/1994	CA2162602A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	CA2162594A1 Insulin-like growth factor ii as antitumour agent
11/24/1994	CA2162496A1 Allogeneic and xenogeneic transplatation
11/24/1994	CA2162478A1 Sialyl lex analogues as inhibitors of cellular adhesion
11/24/1994	CA2162370A1 Composition of antibodies against hepatitis b surface antigen
11/24/1994	CA2162261A1 Methods and formulations for use in treating benign gynecological disorders
11/24/1994	CA2162113A1 Processes and intermediate compounds useful for the preparation of platelet glycoprotein iib/iiia inhibitors
11/24/1994	CA2162055A1 Method for selective opening of abnormal brain tissue capillaries
11/24/1994	CA2161807A1 Bmp-10 compositions

1 ... 2869 2870 2871 2872 2873 2874 2875 2876 2877 2878 2879 2880 2881 2882 2883 2884 2885 2886 2887 2888 2889 ... 3163